Showing posts with label Patient Compliance. Show all posts
Showing posts with label Patient Compliance. Show all posts

Wednesday, November 12, 2008

Wikipedia Entry for Compliance (Medicine)

I was reading Todd Defren's PR Squared blog post today about Wikipedia, and if a company should or should not create an entry for themselves. It got me thinking more about Wikipedia, and using it as a go to source for information.

I do not use Wikipedia regularly, however I find increasingly useful for trivial information, such as who is Lonelygirl15, since I missed all the YouTube ballyhoo.

I think UGC (user generated content) is fantastic, however I do not think it is always an authoritative source. With that in mind, I looked up the my favorite terms: medication adherence, medication non-adherence, medication compliance and medication non-compliance. The only listing was Compliance (Medicine).

From the Wikipedia entry:

"Compliance (or Adherence) is a medical term that is used to indicate a patient's correct following of medical advice. Most commonly it is a patient taking medication (drug compliance), but may also apply to use of surgical appliances such as compression stockings, chronic wound care, self-directed physiotherapy exercises, or attending counselling or other courses of therapy.

Patients may not accurately report back to healthcare workers because fear of possible embarrassment, being chastised, or seeming to be ungrateful for a doctor's care.

Causes for poor compliance include:
• Forgetfulness
• Prescription not collected or not dispensed
• Purpose of treatment not clear
• Perceived lack of effect
• Real or perceived side-effects
• Instructions for administration not clear
• Physical difficulty in complying (e.g. opening medicine containers, handling small tablets, swallowing difficulties, travel to place of treatment)
• Unattractive formulation, such as unpleasant taste
• Complicated regimen
• Cost of drugs"

The listing goes on to discuss "Adherence: An estimated half of those for whom medicines are prescribed do not take them in the recommended way. Until recently this was termed "non-compliance", and was sometimes regarded as a manifestation of irrational behavior or willful failure to observe instructions, although forgetfulness is probably a more common reason. But today health care professionals prefer to talk about "adherence" to a regimen rather than "compliance"...."

And "Drug Compliance: It is estimated that only 50% of patients suffering from chronic diseases in developed countries follow treatment recommendations...."

And "Concordance: Concordance is a current UK NHS initiative to involve the patient in the treatment process and so improve compliance...."

Overall it is a great listing. Wikipedia (rather the authors & editors) address the causes, the percentage of patients who are non-adherent, and the differences between adherence and compliance and concordance.

I guess I will have to live the listing title: Compliance (Medicine).

Monday, August 6, 2007

NCPIE Report

Yes, I have been very late in posting this. I appologize. The NCPIE report that is referenced in many articles around the country and in my last post can be found at http://www.talkaboutrx.com.

Dr. Allan Showalter at Alignmap is always up to date and I cannot express my thoughts about the report better than he at:
http://alignmap.com/category/blog.

Tuesday, July 31, 2007

Another Article on the Horrible State of Medication Adherence

Here's an article that is on the wire. I looked for the study Neergaard references, however could not find it. There are some good nugets in here though:

Taking Our Meds? We Are Not Doing It Well
By LAURAN NEERGAARD
Associated Press – July 31, 2007

WASHINGTON
Consider it the other drug problem: Millions of people don't take their medicine correctly - or quit taking it altogether - and the consequences can be deadly.

On average, half of patients with chronic illnesses, such as heart disease or asthma, skip doses or otherwise mess up their medication, says a report being issued later this week that calls the problem a national crisis costing billions of dollars.

The government is preparing new steps to try to persuade patients and their doctors to do better.

But with contributors that range from too-hurried doctor visits to confusing pill bottles, there's no easy solution.

"We go into this with some humility," said Dr. Carolyn Clancy, director of the Agency for Healthcare Research and Quality, which is planning what she calls an "in your face" campaign to improve medication adherence. "It's really pretty appalling how badly we do."

This goes far beyond the issue of affording prescriptions. Often people buy their drugs, but misunderstand what they're supposed to take, or how. Or forget doses. Or start feeling better and toss the rest of the bottle. Or skip doses for fear of side effects.

It's not just a problem of poverty or poor education. Even the rich and highly educated skip their medicine. Perhaps the most high-profile example is former President Clinton, who stopped taking his cholesterol-lowering statin drug and later needed open-heart surgery to avert a major heart attack. Statins offer significant heart protection, but about half of patients on statins quit using them within a year.

And remember the globe-trotting tuberculosis patient who was briefly quarantined in May after ignoring doctors' orders not to travel by airplane? He's out of the hospital now but, like all patients with hard-to-treat TB, must take his remaining antibiotics while health workers watch. So many TB patients skip their pills when they feel better - but before all the bacteria are wiped out - health departments now enforce what's called "directly observed therapy."

For most diseases, however, patients must choose to take their medicines. The new report combs a decade of research to conclude people generally do a lousy job.

Among findings from the nonprofit National Council on Patient

Information and Education:

Particularly at risk are people whose diseases are initially symptom-free. Although high blood pressure more than triples the risk of heart disease, for example, just 51 percent of patients stick with their prescribed antidote.

Also at high risk are the elderly, but adherence is a problem for all ages. As few as 30 percent of teenagers correctly take drugs to prevent asthma attacks, for example.

Dire consequences aren't always a deterrent. Among patients already blind in one eye from glaucoma, only 58 percent were protecting the other eye. Another study found that 18 percent of kidney transplant recipients weren't following instructions to prevent organ rejection.

Even doctors mess up, acknowledging in one study adhering to their own prescriptions just 79 percent of the time.

Poor medication adherence can cost an extra $2,000 a year for each patient in extra doctor visits alone, and it's associated with as many as 40 percent of nursing home admissions, even more costly.

Add preventable hospitalizations and premature death, and the report estimates that poor medication adherence could be costing the country $177 billion in medical bills and lost productivity.

Why is taking medicines correctly so tough? One reason is the general confusion surrounding drugs, said Dr. Ruth Parker of Emory University, a co-author of the new report who has studied the issue for the American College of Physicians Foundation.

When the pharmacy hands over your prescription, there are bunches of papers - stapled to the bag, outside the box, glued to the bottle - that all bear drug information, but often with different wording.

Bottles are covered in warning stickers - such as "Take with food" or "Swallow whole" or "Don't use with XYZ other drug" - in so many colors that Parker compares pill containers to Christmas trees.

What in that jumble should patients pay most attention to?

Then there's the wording. Parker recently helped test the seemingly simple instruction "Take two tablets twice daily." Did that mean a total of two, or a total of four? A third of patients who were deemed literate got confused. A more clear instruction would be: "Take two tablets in the morning and two tablets at night."

Beyond literacy, poor eyesight plays a role. Pill-bottle instructions are rather tiny.

Whatever the cause, Clancy hopes to make "take your medicine" a new priority. Her Agency for Healthcare Research and QUality is starting discussions with the new report's authors, the FDA and health groups about steps to do that. Options range from attention-grabbing ads about the dangers of misusing medicines to better drug labels.

Atlanta Lawyer with DR-TB in Recovery

I found this in the Gainesville Times over the weekend written by Debbie GIlbert. It doesn't really focus on adherence, but it goes with my TB strand from before. The best adherence is the supervised therapy, but it only is the case with these types of diseases in the US.

Andrew Speaker, the Atlanta attorney who set off an international panic when he flew on commercial airplanes after being diagnosed with drug-resistant tuberculosis, now is living in Hall County, at least temporarily. But health officials say there's no reason for local folks to worry.

"Patients with TB, once they're past the contagious stage, are not a threat to anyone's health," said Dave Palmer, spokesman for District 2 Public Health in Gainesville. "But if they quit taking the medication, it's possible for them to become contagious again."

Speaker spent two months at a Denver hospital, where he underwent surgery July 17 to remove an infected lobe of his lung. He was released from the hospital Thursday, with orders to take antibiotics for two years to eliminate the infection.

Because TB is so difficult to cure, public health rules require patients to undergo directly observed therapy. They must report to their local health department every day, where a staff member watches them take their medication.

Speaker took his first dose at the Hall County Health Department Friday morning. Palmer said Georgia law allows patients to be on a five-day dosing schedule so they don't have to take the medicine on weekends when the department is closed.

April Majors, spokeswoman for the Fulton County Department of Health and Wellness, has said Speaker eventually intends to return to Fulton County, where he would then report to the department there for treatment.

Speaker apparently is spending time in Hall while he continues to recuperate from his surgery. Palmer said he does not know how long Speaker plans to stay. Even if Palmer did know, he said federal privacy laws would prohibit him from disclosing any information.

Palmer added that he did not know whether the health department is taking any special precautions to prevent Speaker from being recognized, since images of the attorney have been widely circulated in the media.

Though Speaker may be one of the most famous patients the Hall County Health Department has ever had, Palmer said his treatment regimen is not unusual.

"We've had other TB patients in District 2 who needed supervised therapy," Palmer said.

In the 13 Northeast Georgia counties comprising District 2, there are currently six patients with active TB, he said.

Palmer said patient compliance is typically not a problem.

"Most people work with us because they want to get well," he said. "If they move to another county, they're pretty up-front about notifying us."

Because of the importance of nonstop treatment in TB cases, Palmer said health officials are vigilant about monitoring the patient's whereabouts.

"If the patient stops coming in for treatment, the staff tries to locate that person and will even go to their home if necessary," he said. "We try to make sure people are where they're supposed to be when they're supposed to be."

Wednesday, July 25, 2007

Spiriva Inhaler to help Compliance

I have been hinting about the new pharmaceutical devices that help aid medical compliance, so it is now time to write. It is the best interest of the pharma brands to come up with devices to make their patients more compliance with their medication regime.

First it makes them money (here’s the math: average drug therapy cost: $200; average length of therapy: 3 months - $600 plus another $200 per person per additional month). Second it makes the patient better (sometimes I like to think the pharma companies want to heal people). When the patients are better, their doctor’s look like they know what they are doing and prescribe the medication to more people – thus making the pharma brand more money to put back into their pockets, I mean R & D. It is a great cycle that compliance fuels.

BI and Pfizer just got European approval for Spiriva Respimat Inhaler for people who suffer from COPD. Here are the highlights from their press release:

"SPIRIVA Respimat represents a major step forward in COPD and inhalation therapy. Many patients find certain inhaler devices difficult to coordinate and use," said Professor Marc Decramer, Respiratory Division, University Hospitals, Katholieke Universiteit Leuven, Belgium. "SPIRIVA Respimat has a unique and sophisticated delivery system, and a user friendly design, making it easy to use and suitable for a broad range of patients with COPD. In addition the long-lasting, soft mist cloud generated by SPIRIVA Respimat ensures optimized delivery of SPIRIVA to the lungs, helping patients breathe more easily," he added.

In clinical studies comparing inhaler devices, patients preferred Respimat Soft Mist Inhaler, which may help increase patient compliance with therapy. The novel dose-delivery system of the SPIRIVA Respimat also means that unlike dry powder inhalers, the dose delivered is not dependent on patients' inspiratory flow.

SPIRIVA(R) (tiotropium), a first-line maintenance therapy for COPD, positively impacts the clinical course of the disease, helping to change the way patients live with their condition. The efficacy of SPIRIVA has been demonstrated by an extensive clinical development programme, which has treated over 25,000 patients. It is the most prescribed brand in COPD in the world.

The SPIRIVA Respimat delivery system relies on energy released from a spring, rather than propellants, to produce a long-lasting, slow moving Soft Mist. The innovative design makes SPIRIVA Respimat easy to use, and the Soft Mist results in improved delivery of SPIRIVA to the lungs, with reduced deposition in the mouth and throat compared to a pressurized metered dose inhaler (pMDI). One study showed that 72% of all patients use pMDIs incorrectly and almost half (47%) have problems with coordinating use of the device.

600 million people worldwide live with COPD and its prevalence is predicted to rise making it the world's third leading cause of death by 2020. It is estimated that up to 50% of Americans and 75% of Europeans with COPD are undiagnosed.””

I don’t know if I believe that 600 million people suffer from COPD, but this is from a pharma company so their measurement for COPD is probably a cough. Even though I think the percentages of undiagnosed COPD are high, I am not surprised that is a commonly undiagnosed condition.

I never had an inhaler, but I remember kids in school with them. It was either very nerdy, kinda neat or something for the bullies to steal. Whatever the case, it was always difficult to get a good pull. With the new spring loaded mist, I can hear all the COPD affected breathe a sigh of relief!

Wednesday, July 11, 2007

Great Article in NJ Star-Ledger

Great article about medication noncompliance in the NJ Star-Ledger by Jeff May. I don't know how to activate the link, but you can paste this in your browser for a good read!
http://www.nj.com/business/ledger/index.ssf?/base/business-0/118386894094430.xml&coll=1&thispage=1

I really like his tagline, "Healthcare's broken link". Very apropos of the problem as it starts with the MD prescribing the pill, to the pharmacist to the patient. I like the links in the chain.

Tuesday, July 10, 2007

Scientologist's Double Murder Down Under Blamed on Noncompliance

Here is something from the Sydney Herald written by Dylan Welch. I don't want to anger the Scientologists, but it really shows their ignorance and the importance of medication compliance - especially with psychiatric treatment.

SCIENTOLOGISTS were condemned yesterday as "flat-earthers", following statements in court that an alleged murderer was denied psychiatric treatment because of her family's Scientologist beliefs.

The vice-president of the Australian Church of Scientology, Cyrus Brooks, told ABC radio the Scientology link to the killings was "a bit of a red herring".

"The woman was actually under the drugs; she was on drugs at the time of the incident. She was also under the care of a psychiatrist … since January," Mr Brooks said.

"The records show that she was on psychiatric drugs, so to say that it had something to do with us, then I think it's incredibly defamatory and unfair."

A psychiatric report tendered to Bankstown Local Court on Monday said the 25-year-old woman accused of murdering her father and sister in Revesby last Thursday had tried to get help twice last year, but her Scientologist parents had a religious objection to psychiatric intervention.

Mr Brooks said modern psychiatry used many methods that were largely "unproven" and psychiatric assumptions such as chemical imbalances in the brain did not exist.

After Mr Brooks finished his interview, a Sydney University psychiatrist, Chris Tennant, phoned ABC Radio to reject the Scientologist's beliefs.

Professor Tennant said it was "so sad to hear the flat-earthers getting on the radio". He denied modern psychiatry was largely unproven and said the amount of research on mental illness was as strong as that for cancer and heart disease.

"It's a tragedy to hear this mumbo jumbo being proselytised by this group," he said. "The sad thing about this sounds to be that this girl may well have been prescribed some psychiatric treatment but living in a family which had the Scientology attitude there is no way there would have been what we term compliance."

The president of the Australian Medical Association, Dr Rosanna Capolingua, said if the woman had had access to appropriate medical treatment, it could have "changed the course of her life".

Media reports yesterday morning said the accused woman's parents had taken her off anti-psychotic medication and instead treated her with non-psychotic medicine imported from the US.

Mr Brooks denied the US medicine had anything to do with Scientology.

He said the church did not give the family any advice on the daughter's situation and had not recommended the US medication she was alleged to have taken.

Mr Brooks said he was not aware of any US medication used for the same purpose.

The woman accused of the double murder is due to appear in court again today.

Friday, June 29, 2007

Patient Compliance: Is There a Solution? - 2

MedAdNews and Guildeline surveyed consumers and physicians to determine their attitudes about patient compliance. I attended their breakfast launch to hear the results and the panel discussion on Wednesday 06.27.07. Most of what they discovered I knew, however I was surprised by some of the stats which I will share here.

Morris Whitcup and Al Koster, both from Guideline, are credited as the authors of this study which was published as The Trend Report in June's MedAdNews. I am going to focus on the facts that I find interesting and were new to me, there is plenty more data in the report which I am not going to address.

Of those polled, 59% (6 in 10) said they were noncompliant during the past year. Pretty Standard.

They broke down the noncompliant by Behaviorally Noncompliant (BN) and Attitudinally Noncompliant (AN). I had never heard of that breakdown and think it is an interesting measure. 27% (1 in 4) of respondents were attitudinally noncompliant - meaning that their answers based on the questions asked, reflected a noncompliant attitude. There was also crossover with behaviorally noncompliant in this group.

After accounting the overlap with the two groups, Guideline found that 64% (2 in 3) polled were noncompliant.
Attitudinally Only: 5%
Behaviorally Only: 37%
Both: 22%
Neither: 36%

The results using this BN and AN were fascinating, as the AN were the most interested in learning more about medications, would be more compliant if they understood the importance of taking medications (60%), were the most knowledgeable in the family about medications (59%), and thought it was OK to skip a dosage or two (39%).

The AH did admit to not being as careful as they should about taking their medications properly (67%) and thankfully the majority said they were more careful with their children's medication that their own (61%). So pretty big numbers, some disturbing, some disappointing - 50% wished their doctor spent more time with them explaining their medication.

The physician's understanding or ideas about patient compliance were a little off the real numbers. Before that though, how long do you think the average doctor spends explaining medications to their patients? 2.9 minutes per the consumers, 3.2 mins per the physicians. That horrifies me. I do not go to the doctor that often, but at my first physical in 6 years Dr. Lim put me on Tricor for my trigliceride levels (diet, lack of exercise and inherited traits were the cause).

I did not time her, but it felt a lot longer than 3 minutes - the reason, what it does, the dosage, the side effects, how long I have to take it - could it all be summed up in three minutes? I also had two telephone conversations with her about it - lab tests, was it working, etc... Maybe I'm wrong about the time, but it is a pretty simple statin. I can't imagine if I had to take a complicated schedule with multiple medications and only have 3 minutes to get everything straight? No wonder the noncompliance rates are so high.

More to come.